Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP435495.RAQS_MAkJJV6Gmn15mrmGOBbyaE6L9VONTK5XQuWSw9eI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP435495.RAQS_MAkJJV6Gmn15mrmGOBbyaE6L9VONTK5XQuWSw9eI130_assertion type Assertion NP435495.RAQS_MAkJJV6Gmn15mrmGOBbyaE6L9VONTK5XQuWSw9eI130_head.
- NP435495.RAQS_MAkJJV6Gmn15mrmGOBbyaE6L9VONTK5XQuWSw9eI130_assertion description "[The aim of our investigation was to characterize the role of group I mGluRs and NMDA receptors in pathomechanisms of experimental autoimmune encephalomyelitis (EAE), the rodent model of MS. We tested the effects of LY 367385 (S-2-methyl-4-carboxyphenylglycine, a competitive antagonist of mGluR1), MPEP (2-methyl-6-(phenylethynyl)-pyridine, an antagonist of mGluR5), and the uncompetitive NMDA receptor antagonists amantadine and memantine on modulation of neurological deficits observed in rats with EAE.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435495.RAQS_MAkJJV6Gmn15mrmGOBbyaE6L9VONTK5XQuWSw9eI130_provenance.
- NP435495.RAQS_MAkJJV6Gmn15mrmGOBbyaE6L9VONTK5XQuWSw9eI130_assertion evidence source_evidence_literature NP435495.RAQS_MAkJJV6Gmn15mrmGOBbyaE6L9VONTK5XQuWSw9eI130_provenance.
- NP435495.RAQS_MAkJJV6Gmn15mrmGOBbyaE6L9VONTK5XQuWSw9eI130_assertion SIO_000772 23936777 NP435495.RAQS_MAkJJV6Gmn15mrmGOBbyaE6L9VONTK5XQuWSw9eI130_provenance.
- NP435495.RAQS_MAkJJV6Gmn15mrmGOBbyaE6L9VONTK5XQuWSw9eI130_assertion wasDerivedFrom befree-20150227 NP435495.RAQS_MAkJJV6Gmn15mrmGOBbyaE6L9VONTK5XQuWSw9eI130_provenance.
- NP435495.RAQS_MAkJJV6Gmn15mrmGOBbyaE6L9VONTK5XQuWSw9eI130_assertion wasGeneratedBy ECO_0000203 NP435495.RAQS_MAkJJV6Gmn15mrmGOBbyaE6L9VONTK5XQuWSw9eI130_provenance.